Strainprint Technologies operates a demand-side cannabis data and analytics platform that gathers real-time cannabis consumption and efficacy data on lab-verified strains and provides enterprise business intelligence. Its Strainprint app is free to patients (iOS and Google Play) and the web-based Strainprint Analytics is available by monthly subscription. The platform supports global cannabis research and supplies BI to producers, retailers, medical practitioners, pharma, government and industry. Strainprint emphasizes privacy and security: its data is HIPAA, PIPEDA and PHIPA compliant, military-grade encrypted, anonymized and stored in Canada. The company plans to use recent funding to hire talent and expand sales and marketing of Strainprint Analytics across North America and into international markets such as Australia and Germany. Strainprint was founded in Toronto in 2016 by CEO Andrew Muroff.

Total raised

$3M

Funding rounds

1

Latest round

Series A

Latest activity

May 2018